Forte Biosciences (FBRX) Payables (2016 - 2020)
Historic Payables for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $1.5 million.
- Forte Biosciences' Payables fell 9497.94% to $1.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.5 million, marking a year-over-year decrease of 9497.94%. This contributed to the annual value of $6.3 million for FY2019, which is 8545.83% up from last year.
- According to the latest figures from Q3 2020, Forte Biosciences' Payables is $1.5 million, which was down 9497.94% from $2.6 million recorded in Q2 2020.
- In the past 5 years, Forte Biosciences' Payables ranged from a high of $30.1 million in Q3 2019 and a low of $1.5 million during Q2 2018
- In the last 5 years, Forte Biosciences' Payables had a median value of $6.8 million in 2019 and averaged $7.5 million.
- Per our database at Business Quant, Forte Biosciences' Payables soared by 56160.26% in 2019 and then crashed by 9497.94% in 2020.
- Over the past 5 years, Forte Biosciences' Payables (Quarter) stood at $8.9 million in 2016, then rose by 3.21% to $9.2 million in 2017, then tumbled by 62.8% to $3.4 million in 2018, then soared by 85.46% to $6.3 million in 2019, then plummeted by 76.03% to $1.5 million in 2020.
- Its last three reported values are $1.5 million in Q3 2020, $2.6 million for Q2 2020, and $6.6 million during Q1 2020.